Clinical & Experimental Allergy

The Editor takes a closer look at some of this month's articles
pp. 303-303(1)

Allergen-independent immunomodulatory activities of immunoglobulin E
pp. 304-306(3)
Authors: Horner, A. A.; Kawakami, T.

New frontiers in allergen standardization
pp. 307-309(3)
Authors: Reuter, A.; Lüttkopf, D.; Vieths, S.

Role of T cells in the pathogenesis of atopic dermatitis
pp. 310-316(7)
Author: Ogg, G.

Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors
pp. 317-324(8)
Author: Bochner, B. S.

On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: an immunochemical perspective
pp. 325-344(20)
Authors: Baldo, B. A.; Fisher, M. M.; Pham, N. H.

Inflammatory and oxidative stress biomarkers in allergic rhinitis: the effect of smoking
pp. 345-353(9)
Authors: Tanou, K.; Koutsokera, A.; Kiropoulos, T. S.; Maniati, M.; Papaioannou, A. I.; Georga, K.; Zarogiannis, S.; Gourgoulianis, K. I.; Kostikas, K.

Airway angiogenesis in patients with rhinitis and controlled asthma
pp. 354-360(7)
Authors: Kristan, S. S.; Malovrh, M. M.; Silar, M.; Kern, I.; Flezar, M.; Kosnik, M.; Suskovic, S.; Korosec, P.

CD200R surface expression as a marker of murine basophil activation
pp. 361-369(9)
Authors: Torrero, M. N.; Larson, D.; Hübner, M. P.; Mitre, E.

Relevance of the hygiene hypothesis to early vs. late onset allergic rhinitis
pp. 370-378(9)
Authors: Matheson, M. C.; Walters, E. H.; Simpson, J. A.; Wharton, C. L.; Ponsonby, A.-L.; Johns, D. P.; Jenkins, M. A.; Giles, G. G.; Hopper, J. L.; Abramson, M. J.; Dharmage, S. C.

Relationship between oxidative stress-related biomarkers and antioxidant status with asthma and atopy in young adults: a population-based study
pp. 379-386(8)
Authors: García-Larsen, V.; Chinn, S.; Rodrigo, R.; Amigo, H.; Bustos, P.; Rona, R. J.

Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis
pp. 387-393(7)
Authors: Malling, H-J.; Montagut, A.; Melac, M.; Patriarca, G.; Panzner, P.; Seberova, E.; Didier, A.

Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment
pp. 394-400(7)
Authors: Horak, F.; Jaeger, S.; Worm, M.; Melac, M.; Didier, A.

Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen
pp. 401-408(8)
Authors: Stelmach, I.; Kaczmarek-Woźniak, J.; Majak, P.; Olszowiec-Chlebna, M.; Jerzynska, J.

Effect of levocetirizine on nasal provocation testing with adenosine monophosphate compared with allergen challenge in allergic rhinitis
pp. 409-416(8)
Authors: Vaidyanathan, S.; Nair, A.; Barnes, M. L.; Meldrum, K.; Lipworth, B. J.

Immunoglobulin E antibodies enhance pulmonary inflammation induced by inhalation of a chemical hapten
pp. 417-425(9)
Authors: Mathias, C. B.; Freyschmidt, E-J.; Oettgen, H. C.

Detection of allergen composition and in vivo immunogenicity of depigmented allergoids of Betula alba
pp. 426-434(9)
Authors: Carnés, J.; Himly, M.; Gallego, M.; Iraola, V.; Robinson, D. S.; Fernández-Caldas, E.; Briza, P.

Allergenicity and immunogenicity of the major mugwort pollen allergen Art v 1 chemically modified by acetylation
pp. 435-446(12)
Authors: Perovic, I.; Milovanovic, M.; Stanic, D.; Burazer, L.; Petrovic, D.; Milcic-Matic, N.; Gafvelin, G.; van Hage, M.; Jankov, R.; Velickovic, T. Cirkovic

Forthcoming meetings
pp. 447-447(1)